Merck tops earnings estimates on strong demand for Keytruda, new drugs even as HPV vaccine sales fall

  • 📰 nbcsandiego
  • ⏱ Reading Time:
  • 50 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 23%
  • Publisher: 51%

News Notícia

Brasil Últimas Notícias,Brasil Manchetes

The company saw strong sales from its top-selling cancer drug Keytruda, recently launched treatments and its animal health business. 

The company saw strong sales from its top-selling cancer drug Keytruda, recently launched treatments and its animal health business.

The pharmaceutical giant narrowed its full-year sales forecast to a range of $63.6 billion to $64.1 billion, from a previous guidance of $63.4 billion to $64.4 billion.Merck also lowered its adjusted profit guidance from a range of $7.72 to $7.77 per share, from a previous forecast of $7.94 to $8.04 per share. That updated outlook reflects a one-time charge of 24 cents per share related to business development deals with Curon Biopharmaceutical and Daiichi Sankyo.Merck posted net income of $3.

But Merck has a handful of new deals under its belt and key drug launches that will help it offset those losses. That includesAnd Capvaxive, a vaccine designed to protect adults from a bacteria known as pneumococcus that can cause serious illnesses and lung infection, was approved in the U.S. in June.Merck's pharmaceutical division, which develops a wide range of drugs, booked $14.94 billion in revenue during the third quarter, up 5% from the same period a year ago.

 

Obrigado pelo seu comentário. Seu comentário será publicado após ser revisado.
Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

 /  🏆 524. in BR

Brasil Últimas Notícias, Brasil Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

3 Bargain Stocks Positioned for Gains After Missing 2024’s RallyStocks Analysis by MarketBeat.com (Leo Miller) covering: S&P 500, Merck & Company Inc, Adobe Systems Incorporated, Applied Materials Inc. Read MarketBeat.com (Leo Miller)'s latest article on Investing.com
Fonte: Investingcom - 🏆 450. / 53 Consulte Mais informação »